ChemicalBook > Product Catalog >Biochemical Engineering >Natural Products >Irinotecan hydrochloride trihydrate
Irinotecan hydrochloride trihydrate
![Irinotecan hydrochloride trihydrate Structure](CAS/GIF/136572-09-3.gif)
- CAS No.
- 136572-09-3
- Chemical Name:
- Irinotecan hydrochloride trihydrate
- Synonyms
- Iriontecan HCL;Irinotecan HCL 3H2O;Irinotecan HydrochL;Irinotecan Trihydrate;CPT-11 HCl Trihydrate;Irinotecan Hydrochlorid;IRINOTECON HCL TRIHYDRATE;IRINOTECAN HCL TRIHYDRATE;Irinotecan HCI Trihydrate;trihydrate,(s)-hydrochlorid
- CBNumber:
- CB6122430
- Molecular Formula:
- C33H45ClN4O9
- Molecular Weight:
- 677.18
- MOL File:
- 136572-09-3.mol
- Modify Date:
- 2023/9/11 17:45:53
Melting point | 250-256°C (dec.) |
---|---|
Boiling point | 257°C(lit.) |
storage temp. | 2-8°C |
solubility | Soluble in DMSO (up to 50 mg/ml), in Water (up to 4 mg/ml) or in Ethanol (up to 4 mg/ml). |
form | White solid. |
color | Yellow |
Water Solubility | Soluble in DMSO at 100mg/ml. Soluble in water at 25mg/ml with warming |
Merck | 14,5091 |
Stability | Stable for 1 year from date of purchase as supplied. Solutions in DMSO, ethanol or distilled water may be stored at -20° for up to 3 months. |
CAS DataBase Reference | 136572-09-3(CAS DataBase Reference) |
SAFETY
Risk and Safety Statements
Symbol(GHS) | ![]() ![]() GHS07,GHS08 |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|
Signal word | Danger | |||||||||
Hazard statements | H302-H372 | |||||||||
Precautionary statements | P260-P264b-P270-P301+P312-P314-P330-P403-P501c | |||||||||
Risk Statements | 22 | |||||||||
Safety Statements | 20/21-22 | |||||||||
RTECS | DW1060750 | |||||||||
HS Code | 29349990 | |||||||||
Toxicity | dog,LD50,intravenous,40mg/kg (40mg/kg),Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 26, Pg. 953, 1995. | |||||||||
NFPA 704 |
|
Irinotecan hydrochloride trihydrate price More Price(2)
Irinotecan hydrochloride trihydrate Chemical Properties,Uses,Production
Chemical Properties
White powder
Uses
Irinotecan Hydrochloride Trihydrate is a DNA topoisomerase inhibitor.
Definition
ChEBI: A hydrate that is the trihydrate form of irinotecan hydrochloride. Onivyde is used in combination with fluorouracil and leucovorin, for the treatment of patients with metastatic adenocarcinoma of the pancreas after disease progression following gemcitabine based therapy. It is converted via hydrolysis of the carbamate linkage to its active metabolite, SN-38, which is ~1000 times more active.
Hazard
Moderately toxic by ingestion.
Irinotecan hydrochloride trihydrate Preparation Products And Raw materials
Global( 478)Suppliers
Supplier | Tel | Country | ProdList | Advantage | Inquiry |
---|---|---|---|---|---|
Cipla Ltd | +912224826000 | Maharashtra, India | 133 | 58 | Inquiry |
Beta Drugs | +91-9316590666 +91-7015991921 | Haryana, India | 34 | 58 | Inquiry |
Shilpa Medicare Limited (SML) | +91-8532238704 +91-9320649838 | Karnataka, India | 61 | 58 | Inquiry |
Basil Drugs AND Pharmaceuticals Pvt Ltd | +91-2249700250 +91-9619320820 | Mumbai, India | 108 | 58 | Inquiry |
Sun Pharmaceutical Industries Ltd. | 91-22-43244324 | Maharashtra, India | 99 | 58 | Inquiry |
Manus Aktteva | +91 (79) 6512-3395 | New Delhi, India | 581 | 34 | Inquiry |
FRESENIUS KABI ONCOLOGY LTD | +86-571-28971376 | New Delhi, India | 21 | 58 | Inquiry |
MAC CHEM PRODUCTS INDIA PVT LTD | +91 22 4093 9000 / 01 | New Delhi, India | 13 | 58 | Inquiry |
LAURUS LABS LTD | +91 891 306 1222 | New Delhi, India | 43 | 58 | Inquiry |
ARCH PHARMALABS LTD | +91-22-4287-1210 | New Delhi, India | 15 | 58 | Inquiry |
Supplier | Advantage |
---|---|
Cipla Ltd | 58 |
Beta Drugs | 58 |
Shilpa Medicare Limited (SML) | 58 |
Basil Drugs AND Pharmaceuticals Pvt Ltd | 58 |
Sun Pharmaceutical Industries Ltd. | 58 |
Manus Aktteva | 34 |
FRESENIUS KABI ONCOLOGY LTD | 58 |
MAC CHEM PRODUCTS INDIA PVT LTD | 58 |
LAURUS LABS LTD | 58 |
ARCH PHARMALABS LTD | 58 |
136572-09-3(Irinotecan hydrochloride trihydrate)Related Search:
Irinotecan-d10 hydrochloride trihydrate
CPT-11 HCl Trihydrate
irinotecan hydrochloride hydrate
Irinotecanhydrochloridetrihydrate(CPT-11)
IRINOTECON HCL TRIHYDRATE
[1,4'-BIPIPERIDINE]-1'-CARBOXYLIC ACID (S)-4,11-DIETHYL-3,4,12,14-TETRAHYDRO-4-HYDROXY-3,14-DIOXO-1H-PYRANO[3',4',6,7]INDOLIZINO[1,2-B]QUINOLIN-9-YL ESTER, HCL TRIHYDRATE
(S)-[1,4'-Bipiperidine]-1'-carboxylic acid 4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl ester hydrochloride trihydrate ,99%
Irinotecan Hydrochloride (100 mg)
Irinotecan Hydrochloride 
Irinotecan Trihydrate
[1,4'-Bipiperidine]-1'-carboxylicacid,(4S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-ylester,hydrochloride,hydrate(1:1:3)
Irinotecan HCl Trihydrate (CaMpto)
Irinotecan, Hydrochloride Salt, Trihydrate
Irinotecan hydrochloride trihydrate, >=99%
(1,4’-bipiperidine)-1’-carboxylicacid,4,11-diethyl-3,4,12,14-tetrahydro-4-hyd
roxy-3,14-dioxo-1h-pyrano(3’,4’:6,7)indolizino(1,2-b)quinolin-9-ylester,mono
trihydrate,(s)-hydrochlorid
IRINOTECAN HYDROCHLORIDE TRIHYDRATE
IRINOTECAN MONOHYDROCHLORIDE TRIHYDRATE
IRINOTECAN HCL TRIHYDRATE
Irinotecan HCL 3H2O
rinotecan hydrochloride trihydrate
(s)-[1,4'-bipiperidine]-1'-carboxylic acid 4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1h-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl ester hydrochloride trihydrate
Irinotecan Hydrochlorid
7-Ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin Hydrochloride Trihydrate
Irinotecan hydrochloride trihydrate CRS
Irinotecan for peak identification
Irinotican Hydrochloride Trihydrate
IrinotecanHydrochlorideTrihydrate>
Irinotecan HydrochL
Irincan hydrochloride trihydrate
Irinotecan hydrochloride trihydrate USP/EP/BP
Irinotican Hydrochloride TrihydrateQ: What is
Irinotican Hydrochloride Trihydrate Q: What is the CAS Number of
Irinotican Hydrochloride Trihydrate Q: What is the storage condition of
Irinotican Hydrochloride Trihydrate Q: What are the applications of
Irinotican Hydrochloride Trihydrate
Irinotecan for peak identification (Y0001831)
Irinotecan for system suitability 1 (Y0001830)
Irinotecan for system suitability 2 (Y0001833)
Irinotecan Hydrochloride (1347609)
Irinotecan hydrochloride trihydrate (Y0001832)
Iriontecan HCL
CPT 11; CAMPTOSAR; CAMPTO; IRINOTECAN
Irinotecan HCI Trihydrate
(S)-4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl [1,4'-bipiperidine]-1'-carboxylate hydrochloride trihydrate
Irinotecan hydrochloride trihydrate 98%
(S)-4,11-Diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3’,4’:6,7]indolizino[1,2-b]quinolin-9-yl [1,4’-Bipiperidine]-1’-carboxylate Hydrochloride Trihydrate
Irinotecan (CPT-11) HCl Trihydrate
(S)-4,11-Diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl [1,4'-bipiperidine]-1'-carboxylate hydrochloride trihydrate
(S)-4,11-Diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3’,4’:6,7]indolizino[1,2-b]quinolin-9-yl [1,4’-Bipiperidine]-1’-carboxylate Hydrochloride Trihydrate
136572-09-3
6572-09-3
36572-09-3
C33H38N4O6HCl3H2O
C33H38N4O6ClH3H2O
C33H45ClN4O9
Inhibitors
Anticancer
Anti-cancer&immunity
API